NasdaqCM - Nasdaq Real Time Price USD
Longeveron Inc. (LGVN)
1.6150
-0.0350
(-2.12%)
As of 12:49:13 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.15M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BALUCH KHOSO Director | Sale at price 2.07 per share. | Direct | 2,588 | Dec 2, 2024 |
| BALUCH KHOSO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| HARE JOSHUA M Officer, Director and Beneficial Owner | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| SOFFER ROCK J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| LEHR PAUL T General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| HARE NEIL E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| UNGARO URSULA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| HASHAD MOHAMED WA'EL AHMED Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| AGAFONOVA NATALIYA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| LOCKLEAR LISA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| MOTWANI NEHA J Director | Stock Award(Grant) at price 1.68 per share. | Direct | 26,880 | Jul 2, 2024 |
| HAJJAR ROGER JOSEPH Director | Stock Award(Grant) at price 1.68 per share. | Direct | 26,880 | Jul 2, 2024 |
| KENDER RICHARD N Director | Stock Award(Grant) at price 1.46 per share. | Direct | 23,280 | May 10, 2024 |
| HARE JOSHUA M Officer, Director and Beneficial Owner | Purchase at price 2.35 per share. | Direct | 350,000 | Apr 11, 2024 |
| SOFFER ROCK J Director | Purchase at price 2.35 per share. | Direct | 325,000 | Apr 11, 2024 |
| HASHAD MOHAMED WA'EL AHMED Chief Executive Officer | Purchase at price 2.35 per share. | Direct | 24,999 | Apr 11, 2024 |
| HASHAD MOHAMED WA'EL AHMED Chief Executive Officer | -- | Direct | -- | Mar 12, 2024 |
| ROSS CATHY Director | Purchase at price 1.31 per share. | Direct | 6,544 | Jan 10, 2024 |
| BALUCH KHOSO Director | Purchase at price 1.40 - 1.43 per share. | Direct | 14,257 | Dec 29, 2023 |
| PFEFFER JEFFREY Director | Purchase at price 1.35 per share. | Direct | 13,500 | Dec 28, 2023 |
| HARE JOSHUA M Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 15,000 | Sep 21, 2023 |
| LEHR PAUL T General Counsel | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 6,000 | Sep 20, 2023 |
| HARE JOSHUA M Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 90,000 | Sep 12, 2023 |
| HASHAD MOHAMED WA'EL AHMED Chief Executive Officer | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 30,000 | Sep 12, 2023 |
| LOCKLEAR LISA Chief Financial Officer | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 15,000 | Sep 12, 2023 |
| SOFFER ROCK J Director | Conversion of Exercise of derivative security at price 3.00 per share. | Direct | 90,000 | Sep 8, 2023 |
| LOCKLEAR LISA Chief Financial Officer | -- | Direct | -- | Jul 31, 2023 |
| AGAFONOVA NATALIYA Officer | -- | Direct | -- | Jul 24, 2023 |
| CLAVIJO JAMES Chief Financial Officer | Sale at price 3.43 - 3.51 per share. | Direct | 81,541 | Jun 29, 2023 |
| PFEFFER JEFFREY Director | -- | Direct | -- | Jun 9, 2023 |
| BALUCH KHOSO Director | -- | Direct | -- | Jun 9, 2023 |
Related Tickers
KTTA Pasithea Therapeutics Corp.
1.6810
-0.53%
VRAX Virax Biolabs Group Limited
1.0644
-4.11%
PSTV Plus Therapeutics, Inc.
0.7650
-9.39%
QNRX Quoin Pharmaceuticals, Ltd.
6.58
-2.52%
REVB Revelation Biosciences, Inc.
2.9500
+3.15%
PALI Palisade Bio, Inc.
0.7424
-3.58%
SNGX Soligenix, Inc.
2.0000
-5.24%
TVGN Tevogen Bio Holdings Inc.
1.0475
+11.75%
ADIL Adial Pharmaceuticals, Inc.
0.7197
+0.80%
CERO CERo Therapeutics Holdings, Inc.
0.9328
+0.84%